Search Results

Displaying Results 6901-6925 of 8009 "'III'"

Dec 02, 2025, 17:53 ET Accord Healthcare anuncia o lançamento do Denosumabe∇ - Segundo Biossimilar em Saúde Óssea

OSVYRTI e o JUBEREQA aprovação do OSVYRTI e do JUBEREQ foi baseada nos resultados de dois ensaios: um ensaio de Fase I e um ensaio de Fase III que atingiram seus desfechos primários. O estudo de Fase I foi um estudo farmacocinético (PK) randomizado, duplo-cego, de três braços, comparando o JUBEREQ

More news about: Accord Healthcare


Dec 02, 2025, 17:50 ET Accord Healthcare anuncia el lanzamiento de Denosumab∇, segundo biosimilar en salud ósea

de OSVYRTI y JUBEREQLa aprobación de OSVYRTI y JUBEREQ se basó en los resultados de dos ensayos: un ensayo de fase I y un ensayo de fase III que cumplieron con sus criterios de valoración principales. El ensayo de fase I fue un ensayo clínico farmacocinético (PK) aleatorizado, de doble ciego

More news about: Accord Healthcare


Dec 02, 2025, 17:31 ET Narcolepsy Market is Projected to Grow at a CAGR of 5.6% During the Forecast Period (2025-2034) Due to Increasing Disease Awareness, Improved Diagnosis, and Expanding Therapeutic Options | DelveInsight

France's Compassionate Use Program for refractory narcolepsy, it has shown robust efficacy, rapid onset, and low abuse potential. The ongoing Phase III AMAZE trials (NLS-1031, NLS-1032) are assessing its effect on weekly cataplexy frequency, followed by a 12-month open-label extension. Leveraging this

More news about: DelveInsight Business Research, LLP


Dec 02, 2025, 16:42 ET EQT completes public offering of common stock of Kodiak Gas Services

2025 /PRNewswire/ -- Frontier TopCo Partnership, L.P. (the "Selling Stockholder"), an affiliate of the funds known as EQT Infrastructure III and EQT Infrastructure IV, is pleased to announce the completion of an underwritten public offering (the "Offering") of 9,762,573 shares of common

More news about: EQT


Dec 02, 2025, 16:40 ET New Data Presented at the Clinical Trials on Alzheimer's Disease (CTAD) Conference 2025 Confirms Pharmacological Effect of LEQEMBI® (lecanemab-irmb) on Neurotoxic Aβ Protofibrils in CSF

fights AD in two ways: targeting both protofibrils and amyloid plaque, which can impact tau downstream.In a CSF sub-cohort (n=410) of the Phase III Clarity AD study, total PF concentration in CSF was quantified using an ultrasensitive assay. Changes from baseline (pre-treatment) for the placebo group

More news about: Eisai Inc.


Dec 02, 2025, 16:33 ET EQT completes public offering of common stock of Kodiak Gas Services

2025 /PRNewswire/ -- Frontier TopCo Partnership, L.P. (the "Selling Stockholder"), an affiliate of the funds known as EQT Infrastructure III and EQT Infrastructure IV, is pleased to announce the completion of an underwritten public offering (the "Offering") of 9,762,573 shares of common

More news about: EQT


Dec 02, 2025, 16:30 ET Contango Announces Acceptance of the Johnson Tract Critical Metals Project to the Covered Projects FAST-41 Program

the Johnson Tract project from the underlying owner, CIRI, (ii) a lease on the Lucky Shot project from the underlying owner, Alaska Hardrock Inc., (iii) 100% ownership of approximately 8,600 acres of peripheral State of Alaska mining claims, and (iv) a 100% interest in approximately 145,000 acres of

More news about: Contango Ore


Dec 02, 2025, 15:45 ET U.S. Department of Energy Selects TVA to Advance Next-Gen Nuclear Energy

DOE selected TVA to receive a $400 million grant to accelerate deployment of the nation's first Gen III + SMR. The funding supports U.S. energy leadership, helping grow a domestic supply chain and workforce for next-generation nuclear technology.TVA's project will serve

More news about: Tennessee Valley Authority


Dec 02, 2025, 15:30 ET Sustainable Markets Initiative Hosts Landmark Private Capital Mobilization Convening in London, with a report back session attended by His Majesty King Charles III

is the defining growth engine of the coming decade.About the Sustainable Markets Initiative Founded by His Majesty King Charles III, the SMI is the world's pre-eminent CEO-led coalition accelerating the transition to a sustainable future.

More news about: Sustainable Markets Initiative


Dec 02, 2025, 15:30 ET Investor Notice: Robbins LLP Informs Investors of the DeFi Technologies Inc. Securities Class Action

other DAT companies and the extent to which that competition would negatively impact its ability to execute its DeFi arbitrage strategy; (iii) as a result of the foregoing issues, the Company was unlikely to meet its previously issued revenue guidance for the fiscal year 2025; and (iv) accordingly,

More news about: Robbins LLP


Dec 02, 2025, 15:25 ET Sustainable Markets Initiative Hosts Landmark Private Capital Mobilization Convening in London, with a report back session attended by His Majesty King Charles III

is the defining growth engine of the coming decade.About the Sustainable Markets Initiative Founded by His Majesty King Charles III, the SMI is the world's pre-eminent CEO-led coalition accelerating the transition to a sustainable future.

More news about: Sustainable Markets Initiative


Dec 02, 2025, 13:01 ET NJFX Advances Campus for AI Infrastructure

Consulting Engineers, shared the firm's longstanding history with NJFX: "Bala was retained in 2015 to design and commission a master plan for a Tier III compliant data center with concurrent maintainability that NJFX needed for future growth. Over the past decade, we've continued to engineer and commission

More news about: NJFX


Dec 02, 2025, 11:12 ET Black Dragon Capital℠ Founder and CEO Louis Hernandez, Jr. To Speak at Big Bright Minds 2025, the Sold-out Filene Research Institute Annual Event Happening from December 2nd to the 4th, in Nashville, TN.

specialize in growing fintech companies have also joined the Black Dragon Capital leadership team.Charles E. ("Chuck") Fagan III, Co-Chair, Black Dragon Capital℠  FinTech Limited Partner Advisory Board Chuck Fagan was appointed president and chief executive officer of

More news about: Black Dragon Capital


Dec 02, 2025, 10:30 ET Axiado Corporation Raises $100M in Series C+ Funding to Advance Platform Security and System Management Solutions for AI Data Centers

Capital focused exclusively on the semiconductor and computing infrastructure sector. Maverick Capital is an investment adviser founded by Lee S. Ainslie III with over thirty years of operating history.Media Contacts:Jeremy HyattGreen Flash Media

More news about: Axiado


Dec 02, 2025, 09:00 ET MKB Announces Closing of its Third Energy Transition Fund

Inc. (MKB), a North American private investment firm, today announced the final close of its third fund, MKB Partners Fund III, L.P. (Fund III). As MKB's largest fund to date, Fund III reinforces the firm's commitment to scaling growth-stage companies that are driving innovation across the power, mobility,

More news about: MKB


Dec 02, 2025, 09:00 ET Investors in Skye Bioscience, Inc. Should Contact Levi & Korsinsky Before January 16, 2026 to Discuss Your Rights - SKYE

effective than defendants had led investors to believe; (ii) accordingly, nimacimab's clinical, regulatory, and commercial prospects were overstated; and (iii) as a result, defendants' public statements were materially false and misleading at all relevant times.WHAT'S NEXT? If you suffered a loss

More news about: Levi & Korsinsky, LLP


Dec 02, 2025, 09:00 ET Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom Lawsuit - DXCM

and G7 less reliable than their prior iterations, presenting a material health risk to users relying on those devices for accurate glucose readings; (iii) accordingly, defendants' purported enhancements to the G7, as well as the device's reliability, accuracy, and functionality, were overstated; (iv) defendants

More news about: Levi & Korsinsky, LLP


Dec 02, 2025, 09:00 ET Firefly Aerospace Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before January 12, 2026 to Discuss Your Rights - FLY

for its Spacecraft Solutions offerings; (ii) Firefly had overstated the operational readiness and commercial viability of its Alpha rocket program; (iii) the foregoing, once revealed, would likely have a material negative impact on the Company; and (iv) as a result, the offering documents and defendants'

More news about: Levi & Korsinsky, LLP


Dec 02, 2025, 09:00 ET CMS Finalizes OPPS Payment for Eko Health's SENSORA® Platform, Expanding Reimbursement for AI-Enabled Cardiac Disease Detection in Hospital-Associated Outpatient Care

identification of heart disease within standard outpatient workflows. This follows CMS's July 2025 proposed rule, which first assigned SENSORA's Category III CPT code (0962T) to APC 5734. The inclusion in the final rule reflects growing institutional support for AI tools that strengthen front-line cardiac

More news about: Eko Health


Dec 02, 2025, 08:30 ET BETTY WOLD JOHNSON FOUNDATION PROVIDES $1 MILLION GRANT TO ECAC LAUNCHING COLLEGE'S LARGEST WOMEN'S FLAG FOOTBALL LEAGUE

(Eastern College Athletic Conference) is an eighty-eight year-old organization with over 200 member schools across all three NCAA Divisions - I, II and III—that exists to enhance the experience of student-athletes participating in intercollegiate athletics, and provide great value for universities and colleges,

More news about: New York Jets


Dec 02, 2025, 08:30 ET TEN Holdings Accelerates Ten Events Pro Development Through Webinar.net Partnership, Unlocking Faster ARR Growth and $1.2-$1.7M in Operational Savings

development of Ten Events Pro puts us years ahead of schedule and opens the door to new opportunities for long-term growth.," said Randolph Wilson Jones III, Chief Executive Officer of TEN Holdings. "By combining Ten Events' expertise in high-quality, reliable production with this advanced technical capability,

More news about: TEN Holdings, Inc.


Dec 02, 2025, 08:15 ET AbbVie to Feature New Data at ASH 2025 Showcasing Continued Advances Across Novel Treatment Modalities in Multiple Blood Cancers

final 1-year follow-up after fixed-duration venetoclax-obinutuzumab (VenO) in first-line (1L) chronic lymphocytic leukemia (CLL): Results from the Phase III CRISTALLO trial 

More news about: AbbVie Inc.


Dec 02, 2025, 08:00 ET UPDATE #1: Khachkar Studios Allocates $10 Million of $100 Million Directly to the "Faithful" of the Armenian Eastern Diocese

sharing publicly, including on our website, 6 assessments of the Eastern Diocese public materials: (i) Briefing Packet #6, (ii) one-page summary memo, (iii) 5-minute podcast, (iv) 7-minute video, (v) one-page financial overview, and (vi) 3-page donor analysis.See

More news about: The Charles & Agnes Kazarian Foundation


Dec 02, 2025, 08:00 ET NXG NextGen Infrastructure Income Fund (NYSE: NXG) Announces Distributions

of equity and debt securities of infrastructure companies, including: (i) energy infrastructure companies, (ii) industrial infrastructure companies, (iii) sustainable infrastructure companies, and (iv) technology and communication infrastructure companies. The Fund will invest no more than 25% of its Managed

More news about: NXG Investment Management


Dec 02, 2025, 07:00 ET LifeStyles Healthcare Appoints Peter Luther to Board of Directors

equity firm. Linden's strategy is based upon three elements: (i) healthcare specialization, (ii) integrated private equity and operating expertise, and (iii) its differentiated human capital program. Since its founding, Linden has invested in over 45 healthcare companies encompassing over 350+ total transactions

More news about: SKYN


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.